The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Levothyroxine Therapy in Patients with Thyroid Disease
Abstract
PURPOSE: To review the indications for and the proper monitoring of levothyroxine therapy in patients with thyroid disease. DATA SOURCES: Relevant English language articles published from 1966 to 1992 were identified through a MEDLINE search and manual searches of both identified articles and selected endocrinology texts. STUDY SELECTION: Studies, case reports, and review articles that contained data on the pathophysiologic aspects of relevant thyroid disorders and on the pharmacologic aspects of, indications for, and administration of levothyroxine therapy. DATA EXTRACTION: Data on the epidemiology, clinical manifestations, complications, and treatment of thyroid disorders were analyzed with respect to patient selection, methods, diagnostic criteria, and conclusions. These data were used to develop a rational approach to the management of such patients. RESULTS OF DATA SYNTHESIS: Levothyroxine is a reliable and commonly prescribed drug to treat thyroid disease, but excessive dosage may have adverse effects. In patients with hypothyroidism, levothyroxine is used as replacement therapy. For most patients, therapy can be initiated with a full replacement dosage (1.6 micrograms/kg body weight), which is usually 75 to 100 micrograms/day for women and 100 to 150 micrograms/d for men. The goal is to normalize the serum thyroid-stimulating hormone concentration. Levothyroxine is also used to suppress the serum thyroid-stimulating hormone concentration. A trial of thyroid-stimulating hormone suppressive therapy is indicated for most patients with benign solitary nonfunctioning thyroid nodules and for those with a history of thyroid cancer. Levothyroxine in non-thyroid-stimulating hormone-suppressive doses may also be indicated for patients with nontoxic multinodular goiter and for certain patients after lobectomy for benign thyroid nodules. CONCLUSIONS: With proper patient monitoring, levothyroxine replacement therapy should be effective, inexpensive, and free of complications. Recommendations for thyroid-stimulating hormone suppression with levothyroxine are based on risk-benefit considerations of the biologic characteristics of the thyroid disorder and the individual patient.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on body weight, hypothyroid patients with minimal endogenous thyroid function require LT4 doses of 1.6-1.8 l g/kg of actual body weight (38,47,212,213,215-217,226,227), although some studies estimate higher doses of 2.0-2.1 l g/kg for some patient groups (212,213,226).”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [47]
In the citing paper
“Most studies examining this issue were retrospective chart reviews (47,212-224), but some studies were prospective (38,225-229).”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [47]
In the citing paper
“Despite this, studies show that for many people levothyroxine dosage is not adjusted as they age because either monitoring for thyroid dysfunction may be not be carried out or indicated dose adjustments identified by monitoring may not be implemented.9 10 11 12 13 14”
From Levothyroxine dose and risk of fractures in older adults: nested case-control study (2011) · cites this paper as [9]
In the citing paper
“While the optimal levothyroxine dose for adults is 1.6-1.8 µg/kg/day,1 9”
From Levothyroxine dose and risk of fractures in older adults: nested case-control study (2011) · cites this paper as [9]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 101–200 of 322
Sommardahl, C. S., Frank, N., Elliott, S. B., Webb, L. L., Refsal, K. R., Denhart, J. W., & Thompson, D. L. (2005) · American Journal of Veterinary Research · doi:10.2460/ajvr.2005.66.1025 · Cited by 49
Schneider, R., Schneider, M., Reiners, C., & Schneider, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2570 · Cited by 48
Levothyroxine replacement dosage determination after thyroidectomy
Jin, J., Allemang, M. T., & McHenry, C. R. (2013) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2012.10.015 · Cited by 47
Fallahi, P., Ferrari, S. M., Ruffilli, I., & Antonelli, A. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0439-y · Cited by 46
Effect of vitamin C on the absorption of levothyroxine in patients with hypothyroidism and gastritis
Jubiz, W., & Ramirez, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4360 · Cited by 45
Colucci, P., D'Angelo, P., Mautone, G., Scarsi, C., & Ducharme, M. P. (2011) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e318217b69f · Cited by 45
Kuo, C., Chao, T., Kao, H., Tsai, Y., Liu, Y., Wang, L. H.-C., Hsieh, M., Chang, S., & Liang, P. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02577-20 · Cited by 45
LACTATING PTU EXPOSURE: I- ALTERS THYROID-NEURAL AXIS IN NEONATAL CEREBELLUMPreprint
Ahmed, R. G., & El‐Gareib, A. W. (2014) · SSRN Electronic Journal · Cited by 43
Once weekly thyroxine treatment as a strategy to treat non-compliance
Rangan, S., Tahrani, A. A., Macleod, A. F., & Moulik, P. K. (2007) · Postgraduate Medical Journal · doi:10.1136/pgmj.2007.060244 · Cited by 42
An aetiological profile of short stature in the Indian subcontinent
Zargar, A. H., LAWAY, B., Masoodi, S. R., Wani, A. I., & SALAHUDDIN, M. (1998) · Journal of Paediatrics and Child Health · doi:10.1046/j.1440-1754.1998.00308.x · Cited by 42
Rosa, G. L. L., Ippolito, A. M., Lupo, L., Cercabene, G., Santonocito, M., Vigneri, R., & Belfiore, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.12.4385 · Cited by 41
Clinical Evolution of Autoimmune Thyroiditis in Children and Adolescents
Fava, A., Oliverio, R., Giuliano, S., Parlato, G., Michniewicz, A., Indrieri, A., Gregnuoli, A., & Belfiore, A. (2009) · Thyroid · doi:10.1089/thy.2008.0239 · Cited by 40
McDermott, M. T., Perloff, J. J., & Kidd, G. S. (1995) · Calcified Tissue International · doi:10.1007/bf00298581 · Cited by 40
Levothyroxine: therapeutic use and regulatory issues related to bioequivalence
Wartofsky, L. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.6.727 · Cited by 38
Dubbs, S. B., & Spangler, R. (2014) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2013.12.003 · Cited by 38
Mohamed, H. M., & El-Twab, S. M. A. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.08.019 · Cited by 38
Levothyroxine dose following thyroidectomy is affected by more than just body weight
Baehr, K. M., Lyden, E., Treude, K., Erickson, J., & Goldner, W. (2012) · The Laryngoscope · doi:10.1002/lary.23186 · Cited by 36
Levothyroxine Replacement Therapy in Central Hypothyroidism: A Practice Report
Carrozza, V., Csako, G., Yanovski, J. A., Skarulis, M. C., Nieman, L., Wesley, R., & Pucino, F. (1999) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.4.349.30940 · Cited by 36
Robertson, H. M. A., Narayanaswamy, A. K. P., Pereira, O., Copland, S. A., Herriot, R., McKinlay, A. W., Bevan, J. S., & Abraham, P. (2014) · Thyroid · doi:10.1089/thy.2013.0661 · Cited by 35
DESTEVEBONETTI, L., Bennet, A., Malet, D., Hoff, M., Jp, L., & Caron, P. J. (2002) · Thyroid · doi:10.1089/105072502320288519 · Cited by 35
Combined T4 and T3 Therapy—Back to the Drawing Board
Cooper, D. S. (2003) · JAMA · doi:10.1001/jama.290.22.3002 · Cited by 35
Thyroid hormone replacement: current status and challenges
Okosieme, O. E. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.600307 · Cited by 33
New questions regarding bioequivalence of levothyroxine preparations: A Clinician's response
Green, W. L. (2005) · The AAPS Journal · doi:10.1208/aapsj070107 · Cited by 32
Van Wilder, N., Bravenboer, B., Herremans, S., Vanderbruggen, N., & Velkeniers, B. (2017) · European Thyroid Journal · doi:10.1159/000452489 · Cited by 31
Skelin, M., Lucijanić, T., Liberati-Čizmek, A.-M., Klobučar, S. M., Lucijanić, M., Jakupović, L., Bakula, M., Lončar, J. V., Marušić, S., Matić, T., et al. (2018) · Endocrine · doi:10.1007/s12020-018-1686-1 · Cited by 31
Midgley, J. E. M., Larisch, R., Dietrich, J. W., & Hoermann, R. (2015) · Endocrine Connections · doi:10.1530/ec-15-0056 · Cited by 31
Rajput, R., & Pathak, V. (2017) · European Thyroid Journal · doi:10.1159/000477348 · Cited by 31
Advances in the management of patients with thyroid disease
Dworkin, H. J., Meier, D. A., & Kaplan, M. M. (1995) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(95)80011-5 · Cited by 31
Managing toxic thyroid adenoma: a cost-effectiveness analysis
Vidal-Trecan, G. M., Stahl, J., & Durand‐Zaleski, I. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460283 · Cited by 31
Rapid levothyroxine absorption testing: a case series of nonadherent patients
Balla, M., Jhingan, R. M., & Rubin, D. J. (2015) · International Journal of Endocrinology and Metabolism · doi:10.5812/ijem.31051 · Cited by 30
Bernareggi, A., Grata, E., Pinorini, M., & Conti, A. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5040621 · Cited by 30
Larijani, B. A., Pajouhi, M., Bastanhagh, M. H., Sadjadi, A., Sedighi, N., & Eshraghian, M. R. (1999) · Endocrine Practice · doi:10.4158/ep.5.5.251 · Cited by 30
Management of Thyroxine Therapy During Pregnancy
Kaplan, M. M. (1996) · Endocrine Practice · doi:10.4158/ep.2.4.281 · Cited by 29
Münte, T. F., Radamm, C. C., Johannes, S., & Brabant, G. E. (2001) · Thyroid · doi:10.1089/10507250152039145 · Cited by 29
Late endocrine, metabolic and skeletal sequelae following treatment of childhood cancer
Gleeson, H. K., Darzy, K. H., & Shalet, S. M. (2002) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2002.0201 · Cited by 29
Lotfi, S., & Veisi, H. (2018) · Chemical Physics Letters · doi:10.1016/j.cplett.2018.12.029 · Cited by 28
Bornschein, A., Paz-Filho, G., Graf, H., & de Carvalho, G. A. (2012) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302012000400006 · Cited by 28
Bagattini, B., Cosmo, C. D., Montanelli, L., Piaggi, P., Ciampi, M., Agretti, P., Marco, G. D., Vitti, P., & Tonacchera, M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0621 · Cited by 28
Alternative Sequences of Thyrotropin and Free Thyroxine Assays for Routine Thyroid Function Testing
Nordyke, R. A., Reppun, T. S., Madanay, L. D., Woods, J. C., Goldstein, A. P., & Miyamoto, L. A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.3.266 · Cited by 28
MORRIS, J. C., Kim, C. K., PADILLA, M. L., & Mechanick, J. I. (1997) · Thyroid · doi:10.1089/thy.1997.7.63 · Cited by 28
Adverse Effects of Thyroid Hormones
Williams, J. (1997) · Drugs & Aging · doi:10.2165/00002512-199711060-00005 · Cited by 28
Baldini, M., Gallazzi, M., Orsatti, A., FOSSATI, S., Leonardi, P., & CANTALAMESSA, L. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00977.x · Cited by 27
Hashimoto's thyroiditis and the role of selenium. Current concepts.
Mazokopakis, E. E., & Chatzipavlidou, V. (2007) · PubMed · Cited by 26
Bolkiny, Y., Tousson, E., El‐Atrsh, A., Akela, M. A., & Farg, E. (2019) · Annual Research & Review in Biology · doi:10.9734/arrb/2019/v31i530063 · Cited by 25
Sarkar, P., Durga, N. D., Morris, J. J., & Martin, J. V. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.002 · Cited by 24
Update on the Management of Hyperthyroidism and Hypothyroidism
Woeber, K. A. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.8.743 · Cited by 24
Ernst, F. R., Sandulli, W., Elmor, R., Welstead, J., Sterman, A. B., & Lavan, M. (2017) · Drugs in R&D · doi:10.1007/s40268-016-0150-z · Cited by 23
Yavuz, D. G., Yazıcı, D., Keskin, L., Atmaca, A., Sancak, S., Saraç, F., Şahin, İ., Dikbaş, O., Hekimsoy, Z., Yalın, S., et al. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00215 · Cited by 23
Clinical Relevancy of the Levothyroxine–Continuous Enteral Nutrition Interaction
Dickerson, R. N., Maish, G. O., Minard, G., & Brown, R. O. (2010) · Nutrition in Clinical Practice · doi:10.1177/0884533610385701 · Cited by 23
El-Twab, S. M. A., & Abdul‐Hamid, M. (2016) · The Journal of Basic and Applied Zoology · doi:10.1016/j.jobaz.2016.10.001 · Cited by 22
Interaction between levothyroxine and calcium carbonate.
Mazokopakis, E. E., Giannakopoulos, T. G., & Starakis, I. (2008) · PubMed Central · Cited by 22
Levothyroxine suppressive therapy: Harmful and useless or harmless and useful?
Bartalena, L., & Pinchera, A. (1994) · Journal of Endocrinological Investigation · doi:10.1007/bf03349686 · Cited by 22
Midgley, J. E. M., Larisch, R., Dietrich, J. W., & Hoermann, R. (2015) · Endocrine Connections · doi:10.1530/ec-150056 · Cited by 31
Short term effects of levothyroxine treatment in thyroid multinodular disease
Cesareo, R., Iozzino, M., Isgrò, M. A., Annunziata, F., & Stasio, E. D. (2010) · Endocrine Journal · doi:10.1507/endocrj.k10e-144 · Cited by 20
Evaluation and treatment of thyroid nodules: a clinical guide
Galofré, J. C., Lomvardias, S., & Davies, T. F. (2008) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20040 · Cited by 20
An Italian Survey of Compliance With Major Guidelines for L-Thyroxine of Primary Hypothyroidism
Vezzani, S., Giannetta, E., Altieri, B., Barbonetti, A., Bellastella, G., Certo, R., Cignarelli, A., Cinti, F., D’Andrea, S., Dalmazi, G. D., et al. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0159 · Cited by 20
Csákó, G., Byrd, D. C., Wesley, R., Sarlis, N. J., Skarulis, M. C., Nieman, L. K., & Pucino, F. (2000) · Medicine · doi:10.1097/00005792-200001000-00002 · Cited by 20
Levothyroxine sodium pentahydrate tablets – formulation considerations
Kaur, N., & Suryanarayanan, R. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.08.006 · Cited by 19
Kaur, N., Young, V. G., Su, Y., & Suryanarayanan, R. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00661 · Cited by 19
Changes in both size and cytological features of thyroid nodule after levothyroxine treatment
Vermiglio, F., Presti, V. P. L., Violi, M. A., Moleti, M., Castagna, M. G., FINOCCHIARO, M. D., Mattina, F., Mandolfino, M. G., Zimbaro, G., & Trimarchi, F. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01854.x · Cited by 18
Food and Levothyroxine Administration in Infants and Children
Zeitler, P. S., & Solberg, P. F. C. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.05.025 · Cited by 18
Beltagy, D. M., Mohamed, T. M., Said, A. S. E., & Tousson, E. (2016) · Environmental Science and Pollution Research · doi:10.1007/s11356-016-6876-x · Cited by 18
RetractedArbelle, J. E., & Porath, A. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00797.x · Cited by 18
Liver Injury Induced by Levothyroxine in a Patient with Primary Hypothyroidism
知孝, 川., Tanaka, A., Negoro, S., Morisawa, Y., Mikami, M., Hojo, M., Yamamoto, T., Uegaki, S., Aiso, M., Kawasaki, T., et al. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.0086 · Cited by 17
Serum Thyrotropin in Primary Hypothyroidism
Kabadi, U. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430100070008 · Cited by 17
Thyroid dysfunction in pregnancy: optimizing fetal and maternal outcomes
Okosieme, O. E., & Lazarus, J. H. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.30 · Cited by 16
Maciel, L. M. Z., & Magalhães, P. K. R. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000700004 · Cited by 15
Draft of the clinical recommendations for diagnosis and treatment of hypothyroidism
Fadeev, V. V., Моргунова, Т. Б., Mel'nichenko, G. A., & Dedov, I. I. (2021) · Clinical and experimental thyroidology · doi:10.14341/ket12702 · Cited by 15
Antúnez, P., & Licht, S. (2011) · Revista Argentina de Endocrinología y Metabolismo · Cited by 15
Isolated Thyroxine Malabsorption Treated With Intramuscular Thyroxine Injections
Anderson, L., Joseph, F., Goenka, N., & Patel, V. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31817ee556 · Cited by 15
Hirata, Y., Fukuoka, H., Iguchi, G., Iwahashi, Y., Fujita, Y., Hari, Y., Iga, M., Nakajima, S., Nishimoto, Y., Mukai, M., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0130 · Cited by 14
Kabadi, U. M., & Kabadi, M. M. (2001) · Endocrine Practice · doi:10.4158/ep.7.1.16 · Cited by 14
EMPATHY: A New Tool for Identifying the Most Suitable Thyroxine Formulation in Hypothyroid Patients
Bellastella, G., Caputo, M., Maiorino, M. I., Longo, M., Scappaticcio, L., Giugliano, D., & Esposito, K. (2019) · Thyroid · doi:10.1089/thy.2018.0493 · Cited by 14
Thyroid suppression test with L‐thyroxine and [99mTc] pertechnetate
Ratnos, C. D., Zantut‐Wittmann, D. E., Tambascia, M. A., da Assumpção, L. V. M., Etchebehere, E., & Camargo, E. E. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00898.x · Cited by 14
Thyroid Hormone, Osteoporosis, and Estrogen
Cooper, D. S. (1994) · JAMA · doi:10.1001/jama.1994.03510400069035 · Cited by 14
Controlled delivery of levothyroxine using porous silicon as a drug nanocontainer
Kashanian, S., Rostami, E., Harding, F. J., McInnes, S. J. P., Al-Bataineh, S., & Voelcker, N. H. (2016) · Australian Journal of Chemistry · doi:10.1071/ch15315 · Cited by 13
Investigating the influence of excipients on the stability of levothyroxine sodium pentahydrate
Kaur, N., & Suryanarayanan, R. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00217 · Cited by 13
Increased prevalence of thyroid dysfunction in Tehran – HAMRAH study
Ghaemmaghami, Z., Firoozbakhsh, P., Gholami, D., Khodabandelu, S., Baay, M., Alemzadeh‐Ansari, M. J., Mohebbi, B., Hosseini, Z., Boudagh, S., Pouraliakbar, H., et al. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01524-x · Cited by 12
Hashimoto's Thyroiditis in Children and Adolescents
Sar, E., Karaoğlu, A., & Yesilkay, E. (2011) · InTech eBooks · doi:10.5772/24755 · Cited by 12
Ésik, O., Tusnády, G., Daubner, K., Németh, G., Füzy, M., & Szentirmay, Z. (1997) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(97)00098-4 · Cited by 12
Prevalence of Iatrogenic Hyperthyroidism in a Community Hospital
Watsky, J., & Koeniger, M. A. (1998) · The Journal of the American Board of Family Medicine · doi:10.3122/15572625-11-3-175 · Cited by 12
Computer-Assisted Levothyroxine Dose Selection for the Treatment of Postoperative Hypothyroidism
Barrio, M. J., Raeburn, C. D., McIntyre, R., Albuja-Cruz, M. B., Haugen, B. R., & Pozdeyev, N. V. (2023) · Thyroid · doi:10.1089/thy.2023.0033 · Cited by 11
The TRHR Gene Is Associated with Hypothalamo-Pituitary Sensitivity to Levothyroxine
Brigante, G., Spaggiari, G., Santi, D., Cioni, K., Gnarini, V. L., Diazzi, C., Pignatti, E., Casarini, L., Marino, M., Tüttelmann, F., et al. (2014) · European Thyroid Journal · doi:10.1159/000358590 · Cited by 11
Is Parenteral Levothyroxine Therapy Safe in Intractable Hypothyroidism?
Peynirci, H., Taşkıran, B., Ertürk, E., Şişman, P., & Ersoy, C. (2017) · Journal of the National Medical Association · doi:10.1016/j.jnma.2017.05.007 · Cited by 12
Consumptive hypothyroidism in an Egyptian baby with benign neonatal hemangiomatosis: a case report
Metwalley, K. A., & Farghaly, H. S. (2013) · Journal of Medical Case Reports · doi:10.1186/1752-1947-7-48 · Cited by 10
Li, R., Xu, Y.-W., Xue, Y., & Wu, X. (2020) · Annals of Palliative Medicine · doi:10.21037/apm-20-190 · Cited by 10
Elmor, R., Sandulli, W., & Carter, C. A. (2017) · Pharmacoeconomics open access · doi:10.4172/2472-1042.1000113 · Cited by 10
Editorial: A Sweetheart Deal for Thyroid Hormone
Lazar, M. A. (2000) · Endocrinology · doi:10.1210/endo.141.9.7736 · Cited by 10
Soldin, O. P., Soldin, S. J., Vinks, A. A., Younis, I., & Landy, H. J. (2010) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181f12fe5 · Cited by 9
Successful Withdrawal of Thyroid Hormone Therapy in Nursing Home Patients
Coll, P., & Abourizk, N. N. (2000) · The Journal of the American Board of Family Medicine · doi:10.3122/15572625-13-6-403 · Cited by 9
Endocrine Diseases of Pregnancy
Edlow, A. G., & Norwitz, E. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00027-5 · Cited by 9
Kundu, S., Roy, S., De, J., Biswas, A., Pramanik, M., & Ray, A. K. (2007) · Neuroendocrinology · doi:10.1159/000107580 · Cited by 9
Lee, Y., Bang, E., Lee, W., & Na, Y. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.113904 · Cited by 8
Mohamed, T. M., Tousson, E., Beltagy, D. M., & Said, A. S. E. (2014) · Biomedicine and Biotechnology · doi:10.12691/bb-2-4-1 · Cited by 8
Mahmoud, M. S. (2020) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v12i4.1145 · Cited by 8
Reverter, J. L., & Colomé, E. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.09.007 · Cited by 8
Singh, R. (2017) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_502_16 · Cited by 8
Vardanyan, R., & Hruby, V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-411492-0.00025-0 · Cited by 8
Clinical Presentation of Spontaneous Primary Hypothyroidism in Adults
Al‐Sultan, A. I., Larbi, E., Magbool, G. M., Karima, T. M., & Bagshi, M. (1995) · Annals of Saudi Medicine · doi:10.5144/0256-4947.1995.143 · Cited by 8
Kabadi, U. M., & Cech, R. F. (1997) · Journal of Endocrinological Investigation · doi:10.1007/bf03350310 · Cited by 8
Metadata
- Authors
- Mandel, S. J., Brent, G. A., & Larsen, P. R.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Mandel, Susan J.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1993-09-15
- Volume
- 119
- Issue
- 6
- Pages
- 492-502
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2017578266
- Cited by
- 324
- References
- 0
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 8 · 2022: 4 · 2021: 11 · 2020: 9 · 2019: 5 · 2018: 6 · 2017: 9 · 2016: 15 · 2015: 12 · 2014: 13 · 2013: 16 · 2012: 14
- FWCI
- 8.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01dk043714-09)
- National Institute of Diabetes and Digestive and Kidney Diseases (1 R01 DK 43714, R01DK036256, T32DK007529)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- levothyroxine, thyroid dysfunction, hypothyroidism, thyroid-stimulating hormone, TSH suppression therapy, thyroid hormone replacement, thyroid nodules, multinodular goiter, thyroid cancer, lobectomy, drug dosing, adverse effects
- MeSH terms
- Female, Humans, Male, Pituitary Gland, Thyroid Diseases, Thyroid Gland, Thyroid Hormones, Thyrotropin, Thyroxine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review